Literature DB >> 35733245

Mitochondrial calcium uniporter promotes phagocytosis-dependent activation of the NLRP3 inflammasome.

Hong Dong1, Bao Zhao1, Jianwen Chen1, Zihao Liu1, Xinghui Li1, Lupeng Li2, Haitao Wen1,3,4.   

Abstract

Mitochondria, a highly metabolically active organelle, have been shown to play an essential role in regulating innate immune function. Mitochondrial Ca2+ uptake via the mitochondrial Ca2+ uniporter (MCU) is an essential process regulating mitochondrial metabolism by targeting key enzymes involved in the tricarboxylic acid cycle (TCA). Accumulative evidence suggests MCU-dependent mitochondrial Ca2+ signaling may bridge the metabolic reprogramming and regulation of immune cell function. However, the mechanism by which MCU regulates inflammation and its related disease remains elusive. Here we report a critical role of MCU in promoting phagocytosis-dependent activation of NLRP3 (nucleotide-binding domain, leucine-rich repeat containing family, pyrin domain-containing 3) inflammasome by inhibiting phagolysosomal membrane repair. Myeloid deletion of MCU (McuΔmye) resulted in an attenuated phagolysosomal rupture, leading to decreased caspase-1 cleavage and interleukin (IL)-1β release, in response to silica or alum challenge. In contrast, other inflammasome agonists such as adenosine triphosphate (ATP), nigericin, poly(dA:dT), and flagellin induced normal IL-1β release in McuΔmye macrophages. Mechanistically, we demonstrated that decreased NLRP3 inflammasome activation in McuΔmye macrophages was caused by improved phagolysosomal membrane repair mediated by ESCRT (endosomal sorting complex required for transport)-III complex. Furthermore, McuΔmye mice showed a pronounced decrease in immune cell recruitment and IL-1β production in alum-induced peritonitis, a typical IL-1-dependent inflammation model. In sum, our results identify a function of MCU in promoting phagocytosis-dependent NLRP3 inflammatory response via an ESCRT-mediated phagolysosomal membrane repair mechanism.

Entities:  

Keywords:  ESCRT; MCU; inflammasome; phagosome

Mesh:

Substances:

Year:  2022        PMID: 35733245      PMCID: PMC9245629          DOI: 10.1073/pnas.2123247119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  51 in total

1.  Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter.

Authors:  Joshua M Baughman; Fabiana Perocchi; Hany S Girgis; Molly Plovanich; Casey A Belcher-Timme; Yasemin Sancak; X Robert Bao; Laura Strittmatter; Olga Goldberger; Roman L Bogorad; Victor Koteliansky; Vamsi K Mootha
Journal:  Nature       Date:  2011-06-19       Impact factor: 49.962

2.  Nuclear factor E2-related factor-2 (Nrf2) is required for NLRP3 and AIM2 inflammasome activation.

Authors:  Changcheng Zhao; Devyn D Gillette; Xinghui Li; Zhibin Zhang; Haitao Wen
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

Review 3.  Enjoy the Trip: Calcium in Mitochondria Back and Forth.

Authors:  Diego De Stefani; Rosario Rizzuto; Tullio Pozzan
Journal:  Annu Rev Biochem       Date:  2016-05-04       Impact factor: 23.643

4.  Type I interferon inhibits interleukin-1 production and inflammasome activation.

Authors:  Greta Guarda; Marion Braun; Francesco Staehli; Aubry Tardivel; Chantal Mattmann; Irmgard Förster; Matthias Farlik; Thomas Decker; Renaud A Du Pasquier; Pedro Romero; Jürg Tschopp
Journal:  Immunity       Date:  2011-02-25       Impact factor: 31.745

Review 5.  Reverse-topology membrane scission by the ESCRT proteins.

Authors:  Johannes Schöneberg; Il-Hyung Lee; Janet H Iwasa; James H Hurley
Journal:  Nat Rev Mol Cell Biol       Date:  2016-10-05       Impact factor: 94.444

6.  ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation.

Authors:  Sebastian Rühl; Kateryna Shkarina; Benjamin Demarco; Rosalie Heilig; José Carlos Santos; Petr Broz
Journal:  Science       Date:  2018-11-23       Impact factor: 47.728

7.  ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences.

Authors:  Yi-Nan Gong; Cliff Guy; Hannes Olauson; Jan Ulrich Becker; Mao Yang; Patrick Fitzgerald; Andreas Linkermann; Douglas R Green
Journal:  Cell       Date:  2017-04-06       Impact factor: 41.582

8.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization.

Authors:  Veit Hornung; Franz Bauernfeind; Annett Halle; Eivind O Samstad; Hajime Kono; Kenneth L Rock; Katherine A Fitzgerald; Eicke Latz
Journal:  Nat Immunol       Date:  2008-07-11       Impact factor: 25.606

9.  Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors.

Authors:  Manuela Rossol; Matthias Pierer; Nora Raulien; Dagmar Quandt; Undine Meusch; Kathrin Rothe; Kristin Schubert; Torsten Schöneberg; Michael Schaefer; Ute Krügel; Sanela Smajilovic; Hans Bräuner-Osborne; Christoph Baerwald; Ulf Wagner
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

10.  Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome.

Authors:  Kiichi Nakahira; Jeffrey Adam Haspel; Vijay A K Rathinam; Seon-Jin Lee; Tamas Dolinay; Hilaire C Lam; Joshua A Englert; Marlene Rabinovitch; Manuela Cernadas; Hong Pyo Kim; Katherine A Fitzgerald; Stefan W Ryter; Augustine M K Choi
Journal:  Nat Immunol       Date:  2010-12-12       Impact factor: 25.606

View more
  2 in total

Review 1.  Involvement of inflammatory responses in the brain to the onset of major depressive disorder due to stress exposure.

Authors:  Shingo Miyata; Yugo Ishino; Shoko Shimizu; Masaya Tohyama
Journal:  Front Aging Neurosci       Date:  2022-07-22       Impact factor: 5.702

Review 2.  Mitophagy: A Potential Target for Pressure Overload-Induced Cardiac Remodelling.

Authors:  Ruochen Shao; Junli Li; Tianyi Qu; Yanbiao Liao; Mao Chen
Journal:  Oxid Med Cell Longev       Date:  2022-09-27       Impact factor: 7.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.